Express Scripts Announces New Recommendations Tackling High Drug Prices
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Formulary Update Positive for Mylan (MYL) - Evercore ISI
August 7, 2018 10:05 AM EDTExpress Scripts' (NASDAQ: ESRX) formulary update today is positive for Mylan's (NYSE: MYL) HIV drug, Evercore ISI analsyt Umer Raffat notes.
"Today, ESRX issued a formulary update where they are now replacing Atripla with SYMFI.... More



